---  
layout: startup_page  
title: "Verdiva Bio"  
id: "verdivabio.com"  
permalink: "/verdivabioverdivabio.com01092025/"  
website: "https://www.verdivabio.com"  
funding_round: "Series A"  
funding_amount: "$411M"  
investors: "Forbion, General Atlantic, RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures, LYFE Capital"  
about: "Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders. They are advancing a portfolio of next-generation oral and injectable treatments with first-in-class or best-in-class potential, including a once-weekly oral GLP-1 receptor agonist and an oral amylin agonist."  
markets: "Biopharmaceutical, Cardiometabolic, Obesity"  
hq: "London, England, United Kingdom"  
founded_year: "2024"  
linkedin: "https://www.linkedin.com/company/verdivabio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/verdiva-bio"  
pitchbook: "https://pitchbook.com/profiles/company/731795-41"  

date_display: "09-Jan-2025"  
date: "2025-01-09"

# SEO Optimization  
meta_title: "Verdiva Bio - Series A Funding ($411M)"  
meta_description: "Verdiva Bio, Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders. ..."  
meta_keywords: "Verdiva Bio, Biopharmaceutical, Cardiometabolic, Obesity, Series A funding"  
canonical_url: "https://startup.projectstartups.com/verdivabioverdivabio.com01092025/"  
---